Organisation paid for research Program year 2024 Source: CMS Open Payments

Cleveland CLNC

Neither a doctor nor a teaching hospital

Research payments

$54,061

45 payments

Through program year 2024, Cleveland CLNC is reported as receiving $54,061 in research payments, across 45 payments.

By program year

3 rows
Year Kind Amount Payments
2024 Research $9 1
2020 Research $21,856 18
2019 Research $32,196 26

Breakdown

Who paid Research payments · program years 2019–2024
  1. Boehringer Ingelheim Pharmaceuticals, Inc. $49,132 7 payments
  2. Boehringer Ingelheim Pharma GmbH & Co.KG $4,920 37 payments
  3. Janssen Research & Development, LLC $9 1 payment
Studies the money was for Research payments · program years 2019–2024
  1. DCRI Registry Study $49,010 5 payments
  2. Extension $3,299 34 payments
  3. Phase I/II monotherapy of low risk MDS $1,626 3 payments
  4. Systemic Sclerosis (ILD) pivotal study $117 2 payments
  5. 78934804Uco2001 $9 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record